As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Royal Bank of Canada, Point72 Asset Management L.P., Man Group plc, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, LMR Partners LLP, J. Goldman & Co LP, Jefferies Financial Group Inc., Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Centiva Capital LP, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, ADAPT Investment Managers SA, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Kovitz Investment Group Partners LLC, Susquehanna International Group LLP, Hsbc Holdings PLC, HAP Trading LLC, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Kopernik Global Investors LLC, Dymon Asia Capital Singapore PTE. LTD., Capital Fund Management S.A., Capula Management Ltd, Wells Fargo & Company MN, One River Asset Management LLC, Valence8 US LP, National Bank of Canada FI, JPMorgan Chase & Co., Mirae Asset Securities USA Inc., Simplex Trading LLC, Twin Tree Management LP, Delta Accumulation LLC, Allianz Asset Management GmbH, Wolverine Asset Management LLC, Valeo Financial Advisors LLC, XY Capital Ltd, Savant Capital LLC, IMC Chicago LLC, Insight Advisors LLC PA, Capital CS Group LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.